Pancreatic Cancer Research

ResearcherUniversity of CopenhagenNo recent work listed

Ola Blixt

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4143-6276; OpenAlex author ID A5049938979. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: 1 paper

Papers 2

  1. A novel monoclonal antibody targeting carboxymethyllysine, an advanced glycation end product in atherosclerosis and pancreatic cancer. Last author DOI 10.1371/journal.pone.0191872↗
  2. Autoantibodies to MUC1 glycopeptides cannot be used as a screening assay for early detection of breast, ovarian, lung or pancreatic cancer. Co-author DOI 10.1038/bjc.2013.214↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ulrika Anna Maria Wendel · 1 shared paper, 2018 · strength 0.08
  2. Brian Burford · 1 shared paper, 2013 · strength 0.02
  3. Celso Albuquerque Reis · 1 shared paper, 2013 · strength 0.02
  4. Michael Anthony Hollingsworth · 1 shared paper, 2013 · strength 0.02
  5. Joy Burchell · 1 shared paper, 2013 · strength 0.02

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.